Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes

There has been an alarming rise in the incidence of esophageal adenocarcinoma which continues to have poor survival rates primarily due to lack of effective chemotherapy and presentation at advanced stages. Over a dozen chemotherapeutic agents are FDA approved for esophageal cancer (EC), and a two o...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Oncol
Huvudupphovsmän: Abdo, Joe, Bertellotti, Carrie A., Cornell, David L., Agrawal, Devendra K., Mittal, Sumeet K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2017
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513914/
https://ncbi.nlm.nih.gov/pubmed/28770168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00151
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk